Sanofi India declares INR 490 dividend per share on the back of divestments and strong domestic growth

The Board of Directors of Sanofi India Limited approved the results for quarter and year ended 2021. The full year PAT increased by 98% from Rs 4,776 million in 2020 to Rs 9,444 million in 2021. The Company approved final dividend of Rs. 490 per share, which includes a special dividend of Rs 309 per share. The total revenue for the year 2021 stood at Rs. 29,566 million with a year-on-year growth of 2%. The domestic business delivered a strong growth of 13% (excluding the impact of the divestment transactions.)

The Company delivered on its commitment to drive operational efficiencies, enhance digital capabilities and reinvent ways of working. The divestment of the Company's nutraceuticals' business in Q3 2021 and the sale of its' Ankleshwar Site in Q2 2020 have also contributed to the lower operational cost. The profit before tax increased from Rs. 6,772 million in the year 2020 to Rs 12,576 million in the year 2021, an increase of Rs 5,804 million, on account of profit from sale of the nutraceuticals' business of Rs 4,892 million in 2021 and increase in operating profit. The return on capital employed was 34.6% (without exceptional items) as compared to 34% in previous year.

Through 2021, while there was a significant rise in the number of COVID-19 cases across the country, the Company stayed focused on affirming the safety and well-being of all our employees and partners; ensured uninterrupted supply of essential medicines; and maintained business continuity of our operations by adopting new ways of working to serve our customers, employees, partners and patients.

Rajaram Narayanan - Managing Director, Sanofi India Limited "We have continued to grow our business in key therapies, while transforming our operations in all areas of the company. Despite the pandemic, our employees have been relentless in serving our patients and customers. Our solid 13% domestic market growth is testimony to their efforts. Recently the Sanofi group has launched a new brand identity that better represents who we are today i.e., a modern healthcare company bringing together dedicated talented people and cutting-edge science to transform the practice of medicine. Our purpose is to chase the miracles of science to improve people's lives."

Shares of Sanofi India Limited was last trading in BSE at Rs. 7183.85 as compared to the previous close of Rs. 7277.45. The total number of shares traded during the day was 2250 in over 954 trades.

The stock hit an intraday high of Rs. 7369.00 and intraday low of 7150.00. The net turnover during the day was Rs. 16328477.00.

Source : Equity Bulls

Keywords

SanofiIndia INE058A01010 Q4CY21 CY2021 Results Dividend